New Senior Investment Group Inc. (SNR)
(Delayed Data from NYSE)
$6.09 USD
+0.50 (8.94%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.08 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.09 USD
+0.50 (8.94%)
Updated May 3, 2019 04:02 PM ET
After-Market: $6.08 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Healthpeak (PEAK) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
While higher occupancy levels at senior housing facilities are likely to have aided Healthpeak (PEAK) in Q3, large asset disposals might have been a deterrent.
Ventas (VTR) Inches Closer to New Senior Investment Merger
by Zacks Equity Research
Ventas (VTR) moves closer toward its proposed merger of New Senior Investment Group with an approval of the latter's stockholders.
Ventas (VTR) Q2 FFO Tops Estimates, Senior Housing Occupancy Up
by Zacks Equity Research
Ventas' (VTR) Q2 results reflect sequential occupancy improvement in its Senior Housing Operating Portfolio segment as well as growth in the Office segment.
What's in the Cards for Ventas (VTR) This Earnings Season?
by Zacks Equity Research
While Ventas (VTR) is well poised to bank on the senior housing industry's recovery that is likely to have aided it in Q2, disposition of assets and higher expenses might have been deterrents.
Healthpeak (PEAK) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
While life-science and medical office portfolios are likely to have aided Healthpeak (PEAK) in Q2, large asset disposals and lower occupancy levels at senior housing facilities are the headwinds.
New Senior Investment Group (SNR) Surpasses Q2 FFO Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 18.18% and -2.06%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Ventas (VTR) to Acquire New Senior Investment in $2.3B Deal
by Zacks Equity Research
Ventas' (VTR) deal to acquire New Senior Investment will poise the healthcare REIT well to capitalize on the senior housing industry's recovery and will likely be accretive to its FFO per share.
Ventas (VTR) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
While the gradual rebound in clinical activity is expected to have supported Ventas' (VTR) office segment performance, the pandemic-led concerns continued to be setbacks for its seniors housing business.
Can Life-Science Assets Aid Healthpeak's (PEAK) Q1 Earnings?
by Zacks Equity Research
Life-science and medical office portfolios are likely to have aided Healthpeak's (PEAK) Q1 performance. Yet, occupancy declines and large asset disposals are expected to have dented revenue growth.
Is Recovery in the Cards for Welltower (WELL) in Q1 Earnings?
by Zacks Equity Research
Despite increased coverage of vaccine administration among senior housing residents, Welltower (WELL) witnesses a significant occupancy decline at its senior housing operating portfolio in Q1.
Life-Science Assets to Aid Ventas (VTR) Amid Pandemic Woes
by Zacks Equity Research
Amid the COVID-19 outbreak, which is taking a toll on Ventas' (VTR) senior housing operations, the company is attuning its portfolio with higher exposure to resilient office segment assets.
Welltower (WELL) Expects 1Q21 FFO to Reach Top-End of Outlook
by Zacks Equity Research
Backed by a rise in vaccination coverage, the removal of admission bans and a spike in move-ins, Welltower's (WELL) seniors housing occupancy decline moderated in March. This will aid Q1 results.
New Senior Investment Group (SNR) Surpasses Q4 FFO and Revenue Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 13.33% and 0.31%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Welltower's (WELL) Seniors Housing Occupancy Slip Continues in Q4
by Zacks Equity Research
While vaccinations renew hope for Welltower's (WELL) seniors housing portfolio, occupancy declines and seasonal move-outs continue to plague its performance.
New Senior Investment Group (SNR) Beats Q3 FFO Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 6.25% and -0.64%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
SNR vs. SUI: Which Stock Is the Better Value Option?
by Zacks Equity Research
SNR vs. SUI: Which Stock Is the Better Value Option?
SNR or SUI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SNR vs. SUI: Which Stock Is the Better Value Option?
New Senior Investment Group (SNR) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 137.50% and 1.09%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
New Senior Investment Group (SNR) Beats Q1 FFO and Revenue Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 6.67% and 0.44%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
New Senior Investment Group (SNR) Tops Q4 FFO Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 20.00% and -25.19%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing New Senior Investment Group (SNR) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for November 29th
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, November 29th
Is New Senior Investment Group (SNR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Strong Buy Stocks for November 22nd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
New Senior Investment Group (SNR) Q3 FFO Beat Estimates
by Zacks Equity Research
New Senior Investment Group (SNR) delivered FFO and revenue surprises of 30.77% and -0.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?